Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Lmln | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Lmln (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of LMLN mRNA | CTD | PMID:17942748 | Lmln | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Lmln (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LMLN mRNA | CTD | PMID:17942748 | Lmln | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Lmln (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LMLN mRNA | CTD | PMID:17942748 | Lmln | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LMLN mRNA | CTD | PMID:33387578 | Lmln | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lmln (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LMLN mRNA | CTD | PMID:21570461 | Lmln | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Lmln | Rat | acrylamide | decreases expression | ISO | Lmln (Mus musculus) | 6480464 | Acrylamide results in decreased expression of LMLN mRNA | CTD | PMID:30807115 | Lmln | Rat | acrylamide | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of LMLN mRNA | CTD | PMID:32763439 | Lmln | Rat | aflatoxin B1 | increases methylation | ISO | LMLN (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of LMLN gene | CTD | PMID:27153756 | Lmln | Rat | avobenzone | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | avobenzone results in decreased expression of LMLN mRNA | CTD | PMID:31016361 | Lmln | Rat | benzo[a]pyrene | decreases methylation | ISO | LMLN (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of LMLN promoter | CTD | PMID:27901495 | Lmln | Rat | benzo[e]pyrene | increases methylation | ISO | LMLN (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of LMLN intron | CTD | PMID:30157460 | Lmln | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of LMLN mRNA | CTD | PMID:25181051 | Lmln | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Lmln | Rat | bisphenol A | increases expression | ISO | LMLN (Homo sapiens) | 6480464 | bisphenol A results in increased expression of LMLN mRNA | CTD | PMID:29275510 | Lmln | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ... | CTD | PMID:36041667 | Lmln | Rat | cadmium atom | multiple interactions | ISO | LMLN (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMLN more ... | CTD | PMID:35301059 | Lmln | Rat | cadmium dichloride | multiple interactions | ISO | LMLN (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of LMLN more ... | CTD | PMID:35301059 | Lmln | Rat | chlorpyrifos | decreases expression | ISO | Lmln (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of LMLN mRNA | CTD | PMID:37019170 | Lmln | Rat | copper atom | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of LMLN mRNA | CTD | PMID:26033743 | Lmln | Rat | copper atom | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of LMLN mRNA | CTD | PMID:26033743 | Lmln | Rat | copper(0) | multiple interactions | EXP | | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of LMLN mRNA | CTD | PMID:26033743 | Lmln | Rat | copper(0) | increases expression | EXP | | 6480464 | Copper deficiency results in increased expression of LMLN mRNA | CTD | PMID:26033743 | Lmln | Rat | cyclosporin A | increases expression | ISO | LMLN (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of LMLN mRNA | CTD | PMID:20106945 | Lmln | Rat | Dibutyl phosphate | affects expression | ISO | LMLN (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of LMLN mRNA | CTD | PMID:37042841 | Lmln | Rat | dibutyl phthalate | decreases expression | ISO | Lmln (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of LMLN mRNA | CTD | PMID:21266533 | Lmln | Rat | dioxygen | increases expression | ISO | LMLN (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of LMLN mRNA | CTD | PMID:24236059 | Lmln | Rat | dorsomorphin | multiple interactions | ISO | LMLN (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Lmln | Rat | doxorubicin | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of LMLN mRNA | CTD | PMID:29803840 | Lmln | Rat | fluoranthene | multiple interactions | ISO | Lmln (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of LMLN mRNA | CTD | PMID:28329830 | Lmln | Rat | furan | decreases methylation | EXP | | 6480464 | furan results in decreased methylation of LMLN gene | CTD | PMID:22079235 | Lmln | Rat | GSK-J4 | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | GSK-J4 results in decreased expression of LMLN mRNA | CTD | PMID:29301935 | Lmln | Rat | maneb | multiple interactions | ISO | Lmln (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of LMLN mRNA | CTD | PMID:36117858 | Lmln | Rat | methapyrilene | increases methylation | ISO | LMLN (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of LMLN intron | CTD | PMID:30157460 | Lmln | Rat | methyl methanesulfonate | increases expression | ISO | LMLN (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of LMLN mRNA | CTD | PMID:23649840 | Lmln | Rat | methylmercury chloride | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of LMLN mRNA | CTD | PMID:28001369 | Lmln | Rat | okadaic acid | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of LMLN mRNA | CTD | PMID:38832940 | Lmln | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of LMLN mRNA | CTD | PMID:26272509 | Lmln | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | LMLN (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Lmln | Rat | paraquat | multiple interactions | ISO | Lmln (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in increased expression of LMLN mRNA | CTD | PMID:36117858 | Lmln | Rat | SB 431542 | multiple interactions | ISO | LMLN (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Lmln | Rat | silver atom | decreases expression | ISO | Lmln (Mus musculus) | 6480464 | Silver results in decreased expression of LMLN mRNA | CTD | PMID:27131904 | Lmln | Rat | silver(0) | decreases expression | ISO | Lmln (Mus musculus) | 6480464 | Silver results in decreased expression of LMLN mRNA | CTD | PMID:27131904 | Lmln | Rat | sodium arsenite | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of LMLN mRNA | CTD | PMID:38568856 | Lmln | Rat | succimer | multiple interactions | ISO | LMLN (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LMLN mRNA | CTD | PMID:26378955 | Lmln | Rat | sunitinib | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of LMLN mRNA | CTD | PMID:31533062 | Lmln | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of LMLN mRNA | CTD | PMID:34492290 | Lmln | Rat | titanium dioxide | decreases methylation | ISO | Lmln (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of LMLN gene | CTD | PMID:35295148 | Lmln | Rat | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of LMLN mRNA | CTD | PMID:33387578 | Lmln | Rat | triphenyl phosphate | affects expression | ISO | LMLN (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of LMLN mRNA | CTD | PMID:37042841 | Lmln | Rat | urethane | decreases expression | ISO | LMLN (Homo sapiens) | 6480464 | Urethane results in decreased expression of LMLN mRNA | CTD | PMID:28818685 | Lmln | Rat | valproic acid | affects expression | ISO | LMLN (Homo sapiens) | 6480464 | Valproic Acid affects the expression of LMLN mRNA | CTD | PMID:25979313 | Lmln | Rat | valproic acid | increases expression | ISO | LMLN (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LMLN mRNA | CTD | PMID:19101580|PMID:24935251 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















